CRISPR Therapeutics (CRSP) Sees IPO Price of $15 - $17/Share
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
CRISPR Therapeutics AG (Nasdaq: CRSP) filed an amended registration with the U.S. SEC for an initial public offering of its common stock. The company plans to sell 4.7 million shares and sees an offering price of $15 to $17 per share.
The offering is being made through Citigroup, Piper Jaffray, Barclays, and Guggenheim Securities.
CRISPR Therapeutics is a leading gene editing company focused on the development of CRISPR/Cas9-based therapeutics.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Caterpillar (CAT) Reports World Machine Sales Down 18% in Sept.
- SAExploration (SAEX) Receives ~$24.4M in Tax Credit Certificates from Alaska's DoR; Can Tap Remaining $15M in Senior Loan Facility
- Community Bank System (CBU) to Acquire Merchants Bancshares (MBVT) in ~$304M Deal
Create E-mail Alert Related CategoriesIPOs
Related EntitiesPiper Jaffray, Citi, Barclays, IPO, Guggenheim
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!